What Is Being Watched: Lannett Company, Inc., Pinnacle Foods (NYSE:PF), 3D Systems Corporation (NYSE:DDD), Can-Fite BioPharma (NYSEMKT:CANF), Intel Corporation (NASDAQ:INTC)

Lannett Company, Inc. (NYSE:LCI) shares advanced 5.44% in last trading session and ended the day at $43.38. LCI Gross Margin is 74.40% and its has a return on assets of 30.60%. Lannett Company, Inc. (NYSE:LCI) quarterly performance is -18.35%.

Lannett Company, Inc. (NYSE: LCI) announced that, following a review of its operations including the recently acquired Kremers Urban Pharmaceuticals Inc. (KU), it expects to achieve approximately $40 million of cost reductions during the first 12 months following the close of the acquisition, with additional savings in later years.

Pinnacle Foods Inc. (NYSE:PF) ended the last trading day at $42.57. Company weekly volatility is calculated as 2.24% and price to cash ratio as 68.00. Pinnacle Foods Inc. (NYSE:PF) showed a weekly performance of 2.49%.

Pinnacle Foods Inc. (NYSE:PF) announced that its Board of Directors has declared a quarterly cash dividend of $0.255 per share, payable on January 8, 2016 to all common stockholders of record at the close of business on December 21, 2015.

On 21 December, 3D Systems Corporation (NYSE:DDD) shares moved down -3.10% and was closed at $10.00. DDD EPS growth in last 5 year was 40.60%. 3D Systems Corporation (NYSE:DDD) year to date (YTD) performance is -69.58%.

3D Systems Co. (NYSE:DDD)‘s stock had its “neutral” rating reissued by stock analysts at Credit Suisse in a research note issued to investors on Monday, Analyst Ratings.Net reports.

Can-Fite BioPharma Ltd. (NYSEMKT:CANF) shares advanced 2.30% in last trading session and ended the day at $3.12. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) quarterly performance is -22.77%.

on 17 December, Can-Fite BioPharma Ltd. (NYSE MKT: CANF) announced that the Japan Patent Office has granted the Company a patent for its lead drug candidate CF101 for the reduction of intraocular pressure (IOP) in a patent titled, “A3 adenosine receptor agonists for the reduction of intraocular pressure.” CF101 is an A3 adenosine receptor (A3AR) agonist that binds to A3AR, which is known to be over-expressed in inflammatory cells.

Intel Corporation (NASDAQ:INTC) caters to the Technology space. It has a net profit margin of 20.80% and weekly performance is -0.67%. On the last day of trading company shares ended up at $34.24. Intel Corporation (NASDAQ:INTC) distance from 50-day simple moving average (SMA50) is -8.92%.

NEC Corporation announced that it will collaborate with Intel Corporation (NASDAQ:INTC) to jointly develop the “Cloud-Radio Access Network (Cloud-RAN) solution” for virtualizing the functions of mobile base stations. Both companies will start a joint proof of concept trial from early 2016 to verify the capabilities of the Cloud-RAN solution.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *